A novel homozygous YARS2 mutation in two italian siblings and a review of literature

JIMD Reports

Volumn 20, Issue , 2015, Pages 95-101

  Ardissone, Anna ^a   Lamantea, Eleonora ^a   Quartararo, Jade ^b   Dallabona, Cristina ^b   Carrara, Franco ^a   Moroni, Isabella ^a   Donnini, Claudia ^b   Garavaglia, Barbara ^a   Zeviani, Massimo ^a,c   Uziel, Graziella ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Mitochondria; Myopathy, lactic acidosis, and sideroblastic anemia; Tyrosyl tRNA synthetase; YARS2

Indexed keywords

EID: 84964474908     PISSN: 21928304     EISSN: 21928312     Source Type: Book Series    
DOI: 10.1007/8904_2014_397     Document Type: Chapter

References (17)

1. Bonnefond L, Frugier M, Touzé E et al (2007) Crystal structure of human mitochondrial tyrosyl-tRNA synthetase reveals common and idiosyncratic features. Structure 15:1505–1516
2. Burrage LC, Tang S, Wang J et al (2014) Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) plus associated with a novel de novo mutation (m.8969G>A) in the mitochondrial encoded ATP6 gene. Mol Genet Metab 14: S1096–S7192
3. Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303–1308
4. Diodato D, Ghezzi D, Tiranti V (2014) The Mitochondrial Aminoacyl tRNA Synthetases: genes and syndromes. Int J Cell Biol 2014:787956
5. Edwards H, Schimmel P (1987) An E. coli aminoacyl-tRNA synthetase can substitute for yeast mitochondrial enzyme function in vivo. Cell 51:6439–6649
6. Fernandez-Vizarra E, Berardinelli A, Valente L, Tiranti V, Zeviani M (2007) Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA). J Med Genet 44:173–180
7. Fujiwara T, Harigae H (2013) Pathophysiology and genetic mutations in congenital sideroblastic anemia. Pediatr Int 55:675–679
8. Hallmann K, Zsurka G, Moskau-Hartmann S et al (2014) A homozygous splice-site mutation in CARS2 is associated with progressive myoclonic epilepsy. Neurology 83:2183–2187
9. Konovalova S, Tyynismaa H (2013) Mitochondrial aminoacyl-tRNA synthetases in human disease. Mol Genet Metab 108:206–211
10. Nakajima J, Eminoglu TF, Vatansever G et al (2014) A novel homozygous YARS2 mutation causes severe myopathy, lactic acidosis, and sideroblastic anemia 2. J Hum Genet 59:229–232
11. Riley LG, Cooper S, Hickey P et al (2010) Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia-MLASA syndrome. Am J Hum Genet 87:52–59
12. Riley LG, Menezes MJ, Rudinger-Thirion J et al (2013) Phenotypic variability and identification of novel YARS2 mutations in YARS2 mitochondrial myopathy, lactic acidosis and sideroblastic anaemia. Orphanet J Rare Dis 8:193
13. Rotig A (2011) Human diseases with impaired mitochondrial protein synthesis. Biochim Biophys Acta 1807:1198–1205
14. Sasarman F, Nishimura T, Thiffault I, Shoubridge EA (2012) A novel mutation in YARS2 causes myopathy with lactic acidosis and sideroblastic anemia. Hum Mutat 33:1201–1206
15. Schwartzentruber J, Buhas D, Majewski J et al (2014) Mutation in The Nuclear-Encoded Mitochondrial Isoleucyl-tRNA Synthetase IARS2 in Patients with Cataracts, Growth Hormone Deficiency with Short Stature, Partial Sensorineural Deafness, and Peripheral Neuropathy or with Leigh Syndrome. Hum Mutat 35:1285–1289
16. Shahni R, Wedatilake Y, Cleary MA, Lindley KJ, Sibson KR, Rahman S (2013) A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations. Am J Med Genet 161:2334–2338
17. Yaremchuk A, Kriklivyi I, Tukalo M, Cusack S (2002) Class I tyrosyl-tRNA synthetase has a class II mode of cognate tRNA recognition. EMBO J 21:3829–3840